Morgan Stanley lowered the firm’s price target on Prosus (PROSY) to $11.10 from $12 and keeps an Overweight rating on the shares as part of a fi...
Morgan Stanley lowered the firm’s price target on Prosus (PROSY) to $11.10 from $12 and keeps an Overweight rating on the shares as part of a fiscal 2026 results preview.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on PROSY:
Disclaimer & DisclosureReport an Issue
Morgan Stanley analyst maintained a Buy rating on Pharmaron Beijing Co., Ltd. Class H on May 28 and set a price target of…
Jefferies lowered the firm’s price target on Copart (CPRT) to $45 from $47 and keeps a Buy rating on the shares following the…
Get the latest analyst rating changes for top companies on Wall Street, including upgrades and downgrades. View complete details…
Top analysts change outlook on top names: BMO, Chardan, Rosenblatt, Susquehanna, Evercore, Deutsche Bank, Baird, Stephens & Co.
In a report released yesterday, James Tate CFA from Goldman Sachs reiterated a Buy rating on Pearson, with a price target of…
UBS upgraded Morgan Stanley to buy from neutral.
